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Abstract
Background: empirical evidence from high-income countries suggests that self-rated health (SRH) is useful as a brief and
simple outcome measure in public health research. However, in many low- and middle-income countries (LMIC) there is a
lack of evaluation and the cross-cultural validity of SRH remains largely untested. This study aims to explore the prevalence
of SRH and its association with mortality in older adults in LMIC in order to cross-culturally validate the construct of SRH.
Methods: population-based cohort studies including 16,940 persons aged ≥65 years in China, India, Cuba, Dominican
Republic, Peru, Venezuela, Mexico and Puerto Rico in 2003. SRH was assessed by asking ‘how do you rate your overall
health in the past 30 days’ with responses ranging from excellent to poor. Covariates included socio-demographic character-
istics, use of health services and health factors. Mortality was ascertained through a screening of all respondents until 2007.
Results: the prevalence of good SRH was higher in urban compared to rural sites, except in China. Men reported higher
SRH than women, and depression had the largest negative impact on SRH in all sites. Without adjustment, those with poor
SRH showed a 142% increase risk of dying within 4 years compared to those with moderate SRH. After adjusting for all
covariates, those with poor SRH still showed a 43% increased risk.
Conclusion: our ﬁndings support the use of SRH as a simple measure in survey settings to identify vulnerable groups and
evaluate health interventions in resource-scares settings.
Keywords: Older people, self-rated health, mortality, low- and middle-income countries, 10/66 Dementia Research Group
Background
Population-based studies in high-income countries have
reported a relationship between older adults’ subjective per-
ception of their overall health and outcomes such as functional
performance, physical activity and morbidity [1, 2]. While self-
rated health (SRH) is a subjective indicator of health status, it
has been found to be a strong predictor of mortality [3, 4], as
it integrates biological, mental, social and functional aspects of
a person, including individual and cultural beliefs and health
behaviours [5]. It is an all-inclusive, sensitive, non-speciﬁc
measure that assesses health and predicts health outcomes in
ways that are still unclear, and not necessarily identical with
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objective health status [6]. Lay deﬁnitions of health take a wide
range of factors into account, and previous and present health
experiences are likely to inﬂuence both what the person review
as potential components of health and the way in which they
are acknowledged [7, 8]. Constituent parts of health known to
inﬂuence SRH, and subsequent mortality, include chronic ill-
ness, depression, cognitive function, socioeconomic status,
functional impairment and physical activity [9, 2]. Studies
show that SRH demonstrates an ability to identify groups with
high future health service use and costs [10, 11], and that
changes in SRH within the same individual over time may be
based on comparisons with the person’s own past health
rather than comparisons of one’s self to same aged peers [3].
In spite of strong empirical evidence from high-income
countries, few studies to date have examined the association
between SRH and mortality in older adults in low- and
middle-income countries (LMIC). Because of the subjective
nature of the indicator, transferability of empirical evidence,
and validity of SRH across cultures is questionable [12],
since context is likely to inﬂuence how people evaluate their
own health. Nonetheless, ﬁndings from a small number of
existing studies on the prevalence of SRH and its predictive
value on mortality and morbidity in LMIC settings appear
to be fairly consistent. Among older adults in China, poor
SRH was positively associated with mortality, cardiovascular
disease, cancer and respiratory disease [13], and childhood
socioeconomic conditions exerted long-term effects on
SRH and mortality, independently of adult and community
socioeconomic conditions [14]. In India, males with poor
SRH had a signiﬁcant increase in mortality hazard, and lack
of spousal support and disability signiﬁcantly increased this
hazard [15]. In Brazil, older adults with poor SRH had a
30% increased 10-year mortality risk compared to persons
with good SRH, and the prevalence of good SRH was asso-
ciated with male sex, more than 5 years of schooling, fewer
diseases [16] and higher household income [17].
Many LMIC are currently undergoing rapid demo-
graphic, social and health transitions were the majority of
older adults are outside the social safety net, posing a chal-
lenge to already overburdened societal systems [18]. Strong
empirical evidence suggests that SRH may be useful as a
brief and simple measure in the context of public health
research, and with practical utility such as identifying vul-
nerable groups in resource-scarce settings for targeted
health interventions [15, 19]. However, older adults’ assess-
ment of SRH is directly contingent on their sociocultural
context. It is important, therefore, to understand the
meaning and impact of SRH cross-culturally. Although the
10/66 Dementia Research Group’s (10/66 DRG) population-
based studies of ageing and dementia has already explored
the predictive validity of dementia [20], frailty [21], social
networks [22] and chronic diseases [23], to our knowledge
the predictive validity of SRH has never been assessed across
a large group of LMIC. This study therefore aims to explore
the prevalence of SRH and its association with mortality in
older adults from China, India and Latin America in order
to cross-culturally validate the construct of SRH.
Method
Setting and study design
The 10/66 Dementia Research Group’s (10/66 DRG)
population-based studies of ageing and dementia in LMIC
comprise baseline surveys of all older adults, aged ≥65
years, living in 11 geographically deﬁned urban and rural
catchment area sites in eight LMIC (see Supplementary
data, Appendix 1, available at Age and Ageing online). The
current secondary analyses include data from urban and
rural sites in China, Mexico, Peru and India, and urban sites
in Cuba, Dominican Republic, Venezuela and Puerto Rico.
Baseline population-based surveys were carried out between
2003 and 2007, and incidence wave follow-up assessments
between 2008 and 2010. The design of the 10/66 DRG
research program has been described in detail elsewhere
[24, 25]. Here, we will describe aspects directly relevant to
the analyses presented in this paper. All study instruments
were translated, back translated by local investigators ﬂuent
in English and local languages and assessed for acceptance
and conceptual equivalence [26]. All participants gave writ-
ten informed consent. Local ethical committees and the
ethical committee of the Institute of Psychiatry, King’s
College London, approved the study.
Measures
Self-rated health
The question concerning SRH was, ‘How do you rate your
overall health in the past 30 days?’ with response options
ranging from ‘very good’, ‘good’, ‘fair’, ‘poor’, to ‘very
poor’. For the statistical analyses, these were combined into
three categories; ‘good’ (including very good), ‘moderate’
and ‘poor’ (including very poor).
Outcome—Mortality
Mortality was ascertained through a screening of all respon-
dents in the follow-up phase of the study. A verbal autopsy
interview with a suitable key informant was completed to
ascertain the cause of death. Date of death was also recorded.
Covariates—Socio-demographic characteristics and
use of community health services
Information on age, sex, educational level, use of community
health services (i.e. primary care, hospital services, private
doctors and traditional healers) during the last 3 months, and
number of household assets was collected using a standard
socio-demographic questionnaire.
Covariates—Health factors
Health conditions diagnosed by a physician were self-reported.
In the present study, we used the following health conditions
in our analysis; dementia, stroke, hypertension, chronic
obstructive pulmonary disease (COPD), diabetes, depression
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and anxiety. Dementia diagnosis was made according to
10/66 criteria [26]. Systolic and diastolic resting blood pressure
was measured in all respondents. Hypertension was ascer-
tained according to the European Society of Hypertension cri-
teria and/or a positive answer to the question ‘have you ever
been told by a doctor that you have hypertension?’ COPD
was diagnosed in those who responded ‘yes’ to the questions
‘do you usually cough up phlegm from your chest ﬁrst thing
in the morning?’ and ‘for how many months of the year does
this usually happen?’ was 3 months or more. Diabetes and
stroke were ascertained by a positive answer to the question
‘have you ever been told by a doctor that you have diabetes/
stroke?’ Depression was ascertained according to the EURO-
D [27]. Those scoring 4 or more on the scale was subse-
quently described as cases of EURO-D depression [28].
Anxiety was assessed using the Geriatric Mental State
Examination [29], together with its diagnostic algorithm, the
Automated Geriatric Examination for Computer Assisted
Taxonomy (AGECAT). Respondents who reached level three
in the GMS/AGECAT stage I anxiety axis were considered
cases, as this threshold normally reﬂects a severity that war-
rants professional intervention [30]. Disability was assessed
using the 12-item version of the WHODAS, a culture-fair
assessment of difﬁculties during the past 30 days due to dis-
eases or illnesses, other health problems that may be short or
long lasting, injuries, mental or emotional problems, and pro-
blems with alcohol or drugs [30, 31].
Analysis
All data were double entered into EPIDATA software and
data analyses were performed using STATA version 14. For
this study, we used the 10/66 data archive (release 3.4;
March 2015). We reported the prevalence of SRH by sex
and age group by study site, generating robust standard
errors and 95% conﬁdence intervals (CI). We used stand-
ardisation to compare the prevalence of SRH among the
sites having adjusted for the compositional effects of age,
sex and educational level (direct standardisation with the
whole sample as the standard population). We used Poisson
regression analysis to describe the association between
SRH, socio-demographics and health factors across sites.
We ﬁtted the models separately for each site and used a
ﬁxed effects meta-analysis to combine them, estimating the
degree of heterogeneity using Higgins’ I2. Cox proportional
hazards models were then applied to examine the associa-
tions between ‘poor’ and ‘good’ SRH with mortality using
‘moderate’ SRH as reference (OR = 1.0) with a step-wise
adjustment for all covariates. Again, we ﬁtted the models
separately for each site and then used a ﬁxed effects meta-
analysis to combine them, along with Higgins’ I2.
Results
Sample characteristics
In total, 16,940 persons aged ≥65 years participated in the
study at baseline. Response proportions varied between
72% and 98% across sites (mean response rate 86%).
Median years of follow-up was 4 years (range 2–5 years).
Socio-demographic characteristics by study site are pre-
sented in Supplementary Table 1, available at Age and Ageing
online.
Prevalence of SRH
Table 1 shows the prevalence of SRH combined into three
categories by sex and site. With the exception of China,
SRH was higher in urban than rural sites. The highest
prevalence of good SRH was found in urban India (76.8%,
95% CI 73.7–80.0%), followed by rural China (62.1%, 95%
CI 59.4–64.9%), and Venezuela (57.5%, 95% CI
54.9–60.2%). The highest prevalence of poor SRH was
found in Cuba (9.8%, 95% CI 8.2–11.3%), followed by
Dominican Republic (8.8%, 95% CI 7.4–10.3%), and rural
Mexico (8.7%, 95% CI 6.1–11.4%). Supplementary Table 2,
available at Age and Ageing online, shows the prevalence
ratios of SRH by site with the ﬁve levels of SRH as mea-
sured in the original survey. Supplementary Table 3, avail-
able at Age and Ageing online, shows the prevalence of SRH
by age group and site. Table 2 shows the mutually adjusted
prevalence rations from a Poisson regression analysis
describing the association between poor SRH and socio-
demographic factors and health factors.
Association between SRH and mortality
The Cox proportional hazards models are presented in
Table 3. In the unadjusted model (Model 1), respondents
with poor SRH had a 142% increased risk of death within
4 years compared to respondents with moderate SRH
(HR = 2.42, 95% CI 1.91–3.07). When adjusting socio-
demographic characteristics and use of community health
service (Model 2), respondents with poor SRH had a 97%
increased risk compared to respondents with moderate
SRH (HR = 1.97, 95% CI 1.74–2.23). When adjusting for
socio-demographic characteristics, use of community health
service, and health factors (Model 3), those with poor SRH
had a 61% increase risk compared to respondents with
moderate SRH (HR = 1.61, 95% CI 1.40–1.86). In the
ﬁnal model (Model 4), we also adjusted for disability
according to WHODAS which showed that those with
poor SRH still had a 43% increased risk compared to those
with moderate SRH (HR = 1.43, 95% CI 1.23–1.66). The
pooled estimates showed that respondents with good SRH
had 10% reduction in risk compared to respondents with
moderate SRH (HR = 0.90, 95% CI 0.82–0.99).
Discussion
This study aimed to explore the prevalence of SRH and its
association with mortality in older adults from China, India
and Latin America in order to cross-culturally validate the
construct of SRH. In comparison with older adults rating
their health as moderate, those rating it as poor had a 142%
Self-rated health and its association with mortality in older adults
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increased risk of dying within 4 years. After controlling for
socio-demographic characteristics, use of community health
service, health factors and disability, those with poor SRH
had a 43% increased risk compared to individuals assessing
their health as moderate. We also found that individuals rat-
ing their health as good had a 10% reduction in risk com-
pared to individuals assessing their health as moderate. This
consistent association between SRH and mortality is in
accordance with ﬁndings from high-income countries [3, 4],
and our ﬁndings support the use of SRH as a simple meas-
ure in survey settings to identify vulnerable groups and to
evaluate health interventions in resource-scares settings. As
a person may be intuitively aware of pathologic processes
before they become measurable, SRH could be a valuable
instrument for identifying older adults at risk [32–34].
Studies suggests that SRH may act as a proxy for other cov-
ariates that are known to predict health [1, 3]; it may reﬂect
experiential knowledge grounded in both bodily experience
and social interaction [35, 36]; it may be associated with ser-
um inﬂammatory markers [37], or it may reﬂect perceived
declines in health, rather than current health levels [2–4]. In
addition, previous and present health experiences are likely
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Prevalence ratios (95% CI) of SRH by gender and site
Men Women Crude prevalence (95% CI) Standardised prevalence (95% CI)a
Cuba
Good 62.16 (59.14–65.09) 47.82 (45.55–50.11) 52.84 (51.01–54.67) 51.07 (48.39–53.75)
Moderate 31.03 (28.26–33.95) 41.64 (39.43–43.87) 37.92 (36.18–39.70) 39.15 (36.5–41.81)
Poor 6.81 (5.42–8.52) 10.54 (9.23–12.01) 9.23 (8.23–10.34) 9.77 (8.20–11.33)
Dom Rep
Good 56.22 (52.46–59.91) 44.23 (41.54–46.95) 48.33 (46.09–50.58) 51.93 (49.35–54.50)
Moderate 35.43 (31.90–39.13) 46.04 (43.34–48.75) 42.41 (40.21–44.64) 39.00 (36.50–41.52)
Poor 8.35 (6.49–10.67) 9.74 (8.24–11.46) 9.26 (8.06–10.62) 8.84 (7.39–10.29)
Peru (U)
Good 60.74 (56.41–64.90) 53.45 (50.11–56.75) 56.04 (53.33–58.71) 47.60 (43.63–51.57)
Moderate 34.36 (30.35–38.60) 41.36 (38.10–44.69) 38.86 (36.26–41.54) 44.85 (40.91–48.79)
Poor 4.91 (3.32–7.21) 5.20 (3.91–6.87) 5.09 (4.04–6.41) 7.09 (4.59–9.59)
Peru (R)
Good 56.03 (49.89–61.99) 61.90 (56.22–67.29) 59.17 (54.82–63.37) 56.91 (52.83–60.99)
Moderate 42.41 (36.50–48.55) 35.71 (30.44–41.36) 38.84 (34.68–43.16) 38.52 (34.45–42.59)
Poor 1.56 (0.59–4.07) 2.38 (1.14–4.91) 2.00 (1.11–3.57) 2.00 (0.81–3.20)
Venezuela
Good 66.38 (62.82–69.77) 54.97 (52.14–57.77) 59.15 (56.84–61.41) 57.50 (54.87–60.13)
Moderate 30.34 (27.06–33.84) 39.77 (37.04–42.56) 36.32 (34.13–38.57) 36.51 (33.94–39.08)
Poor 3.28 (2.19–4.88) 5.26 (4.14–6.66) 4.53 (3.68–5.57) 4.99 (3.89–6.07)
Mexico (U)
Good 55.49 (50.15–60.71) 49.92 (46.14–53.71) 51.80 (48.72–54.86) 52.79 (49.68–55.90)
Moderate 37.39 (32.35–42.71) 40.60 (36.92–44.39) 39.52 (36.55–42.57) 37.78 (34.74–40.82)
Poor 7.12 (4.83–10.39) 9.47 (7.47–11.94) 8.68 (7.05–10.65) 8.26 (6.53–9.99)
Mexico (R)
Good 54.52 (49.56–59.40) 49.00 (45.01–53.01) 51.20 (48.05–54.34) 47.80 (44.01–51.61)
Moderate 37.69 (33.02–42.60) 42.19 (38.28–46.21) 40.40 (37.30–43.58) 37.18 (33.16–41.20)
Poor 7.79 (5.53–10.87) 8.80 (6.79–11.34) 8.40 (6.84–10.27) 8.73 (6.10–11.37)
China (U)
Good 14.83 (11.98–18.22) 15.43 (12.87–18.39) 15.17 (13.07–17.54) 15.57 (13.27–17.88)
Moderate 82.16 (78.56–85.27) 80.48 (77.29–83.32) 81.21 (78.70–83.48) 79.45 (76.98–81.92)
Poor 3.01 (1.82–4.93) 4.08 (2.82–5.88) 3.62 (2.70–4.85) 3.96 (2.88–5.03)
China (R)
Good 67.26 (62.74–71.49) 70.14 (66.22–73.80) 68.66 (65.67–71.88) 62.12 (59.37–64.88)
Moderate 27.35 (23.42–31.67) 26.62 (23.13–30.43) 26.95 (24.11–29.98) 17.17 (14.65–19.69)
Poor 5.38 (3.63–7.90) 3.24 (2.05–5.07) 4.19 (3.12–5.60) 3.55 (2.13–4.98)
India (U)
Good 84.01 (80.17–87.22) 73.91 (70.12–77.37) 78.27 (75.59–80.72) 76.82 (73.66–79.98)
Moderate 12.89 (10.00–16.45) 20.49 (17.36–24.03) 17.15 (14.94–19.61) 17.01 (14.33–19.69)
Poor 3.10 (1.81–5.27) 5.60 (3.99–7.82) 4.59 (3.45–6.07) 4.62 (2.75–6.50)
India (R)
Good 29.52 (25.52–33.86) 22.02 (18.75–25.67) 25.43 (22.79–28.25) 28.69 (24.80–32.58)
Moderate 61.01 (56.44–65.40) 68.07 (64.05–71.84) 64.86 (61.88–67.74) 46.62 (42.69–50.56)
Poor 9.47 (7.10–12.52) 9.91 (7.66–12.72) 9.71 (8.03–11.70) 3.96 (3.10–4.83)
Puerto Rico
Good 64.12 (60.40–67.68) 49.96 (47.28–52.64) 54.60 (52.37–56.80) 52.05 (48.68–55.43)
Moderate 28.24 (24.93–31.82) 41.80 (39.17–44.47) 37.36 (35.24–39.54) 40.26 (36.91–43.61)
Poor 7.63 (5.84–9.92) 8.24 (6.89–9.83) 8.04 (6.93–9.31) 7.68 (6.15–9.22)
aStandardised by age, sex and education (U = Urban; R = Rural; Dom Rep = Dominican Republic).
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to inﬂuence both the range of factors that a person reviews
as potential components of SRH, and the way in which
they are taken into account [38].
The analyses in this study were conducted on large
population-based samples, hence allowing us to assess the
consistency or cultural speciﬁcity of the observed associa-
tions. Diverse cultural patterns of experiencing and reporting
illness and health may have several origins that call for crit-
ical scrutiny taking note of positional perspectives [39, 40],
and the general morbidity in a population may inﬂuence
the understanding of which symptoms that warrant atten-
tion [6, 8]. Age-related changes in coping suggests that dif-
ferent age-groups may act differently in response to chronic
symptoms, since older adults may attribute them to ageing
rather than to illness, and people living in different cultures
may vary in their willingness to present positive or negative
pictures of themselves [41].
The strengths of this study include the use of a large,
population-based sample with over 50,000 person-years of
follow-up. To our knowledge, this is the ﬁrst international
study using standardised questionnaires to assess the rela-
tionship between SRH and mortality across a wide range of
cultures in LMIC. However, some limitations deserve men-
tioning. Every effort was made to ensure conceptual
equivalence of all items included in study instruments. In
addition to translation and back translation procedures, all
teams underwent substantial training to ensure a consistent
approach in the administration of measures across settings,
in accordance with manualised standard operational proce-
dures. However, cross-cultural differences in understand-
ings cannot be eliminated. The extent to which there were
variations in comprehension of the SRH question is
unclear. Our ﬁndings may not be generalisable beyond the
particular catchment area sites where the study was carried
out, and should not be taken to refer to the respective
countries as a whole. In this study, catchment areas selected
were as representative as possible of the wider geographical
region. For urban catchment areas, predominantly middle-
class or professional areas with high-income earners were
avoided. Rural areas were deﬁned by low population density
and traditional agrarian lifestyle.
SRH was assessed at baseline in late life, with no infor-
mation regarding either exposure earlier in the life course,
or subsequent changes in SRH. We acknowledge the poten-
tial risk of over adjustment, since age, sex, household assets,
educational level, use of community health services, health
factors and disability, may mediate the association between
SRH and mortality. Potentially important factors such as
social capital, activity engagement and sense of community
are likely to have inﬂuenced the association between SRH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2. Mutually adjusted prevalence ratios from a Poisson regression analysis describing the association between poor
SRH and age, sex, educational level, number of assets, use of community health services and health factors across sites
(U = Urban; R = Rural; Dom Rep = Dominican Republic)
Centre Age Sex Household assets Educational level Community health service Dementia
Cuba 1.00 (1.00–1.01) 0.84 (0.75–0.94) 0.96 (0.91–1.01) 0.98 (0.93–1.03) 1.27 (1.15–1.41) 1.01 (0.85–1.19)
Dom Rep 1.00 (1.00–1.01) 0.91 (0-80-1.03) 0.96 (0.92–1.00) 0.98 (0.92–1.05) 1.31 (1.17–1.48) 1.01 (0.84–1.21)
Peru (U) 1.00 (0.99–1.02) 0.99 (0.82–1.18) 0.90 (0.80–1.01) 0.85 (0.78–0.93) 1.44 (1.21–1.70) 1.15 (0.84–1.57)
Peru (R) 1.01 (0.98–1.02) 1.34 (1.02–1.77) 0.95 (0.86–1.05) 0.90 (0.78–1.05) 1.45 (1.09–1.92) 1.77 (1.14–2.76)
Venezuela 1.01 (1.00–1.02) 0.86 (0.73–1.01) 0.97 (0.91–1.04) 0.99 (0.92–1.08) 1.42 (1.20–1.67) 1.06 (0.80–1.39)
Mexico (U) 0.99 (0.98–1.01) 0.97 (0.81–1.17) 1.01 (0.93–1.09) 0.97 (0.90–1.04) 1.25 (1.01–1.54) 0.96 (0.70–1.32)
Mexico (R) 1.00 (0.99–1.02) 1.04 (0.87–1.25) 0.98 (0.94–1.03) 1.06 (0.95–1.17) 1.19 (0.99–1.44) 1.37 (1.03–1.82)
China (U) 0.99 (0.98–1.01) 0.99 (0.86–1.14) 1.01 (0.92–1.12) 1.00 (0.95–1.05) 1.04 (0.91–1.19) 0.99 (0.72–1.38)
China (R) 1.01 (0.99–1.03) 1.30 (1.02–1.66) 0.92 (0.85–0.99) 0.89 (0.78–1.02) 2.20 (1.60–3.02) 1.25 (0.73–2.15)
India (U) 1.01 (0.99–1.03) 0.63 (0.47–0.84) 0.88 (0.80–0.96) 1.09 (0.96–1.24) 2.07 (1.55–2.77) 1.36 (0.92–2.01)
India (R) 1.02 (1.00–1.03) 1.00 (0.84–1.18) 0.97 (0.92–1.02) 0.91 (0.82–1.02) 1.33 (1.10–1.61) 1.24 (0.99–1.57)
Puerto Rico 1.01 (1.00–1.02) 0.83 (0.72–0.97) 0.99 (0.98–1.10) 0.91 (0.86–0.97) 1.56 (1.26–1.93) 1.12 (0.89–1.41)
Pooled estimate 1.01 (1.00–1.01) 0.93 (0.89–0.98) 0.96 (0.94–0.98) 0.96 (0.94–0.98) 1.32 (1.26–1.39) 1.11 (1.03–1.2)
I2 23.9% 64.4% 0% 53.6% 70.6% 11.5%
Centre Stroke Hypertension COPD Diabetes Depression Anxiety
Cuba 1.36 (1.16–1.60) 1.09 (0.97–1.23) 1.34 (1.07–1.67) 1.24 (1.11–1.40) 1.68 (1.49–1.89) 1.15 (1.09–1.21)
Dom Rep 1.18 (0.99–1.42) 1.17 (1.01–1.36) 1.47 (1.22–1.76) 1.11 (0.95–1.29) 1.69 (1.48–1.93) 1.17 (1.11–1.23)
Peru (U) 1.36 (1.05–1.76) 1.11 (0.94–1.31) 1.11 (0.82–1.50) 0.98 (0.75–1.29) 1.64 (1.35–1.98) 1.10 (1.03–1.18)
Peru (R) 1.27 (0.71–2.25) 1.51 (1.14–2.01) 1.44 (0.69–3.00) 1.23 (0.82–1.83) 0.97 (0.69–1.36) 1.26 (1.06–1.50)
Venezuela 1.16 (0.93–1.46) 1.20 (0.98–1.47) 1.24 (0.97–1.58) 1.13 (0.95–1.34) 1.77 (1.49–2.10) 1.15 (1.08–1.22)
Mexico (U) 1.30 (0.97–1.73) 1.15 (0.95–1.39) 1.11 (0.80–1.53) 1.04 (0.86–1.26) 1.68 (1.37–2.06) 1.12 (1.02–1.23)
Mexico (R) 1.03 (0.77–1.39) 1.01 (0.85–1.21) 1.38 (1.06–1.79) 1.29 (1.06–1.58) 1.56 (1.28–1.90) 1.19 (1.07–1.31)
China (U) 1.23 (0.98–1.53) 0.97 (0.85–1.11) 0.94 (0.64–1.39) 1.03 (0.87–1.22) 1.31 (0.95–1.82) 0.96 (0.80–1.17)
China (R) 1.27 (0.69–2.34) 3.92 (2.88–5.32) 1.40 (0.77–2.56) 2.14 (1.03–4.42) 2.11 (1.04–4.29) 1.20 (0.83–1.74)
India (U) 3.03 (1.73–5.29) 0.87 (0.66–1.14) 1.52 (0.74–3.13) 1.59 (1.14–2.20) 2.10 (1.59–2.79) 1.30 (1.14–1.48)
India (R) 0.82 (0.30–2.20) 1.06 (0.92–1.22) 1.12 (0.87–1.45) 1.09 (0.82–1.44) 0.98 (0.80–1.21) 1.12 (0.98–1.28)
Puerto Rico 1.30 (1.06–1.60) 1.41 (1.15–1.72) 1.45 (1.09–1.94) 1.46 (1.28–1.66) 1.65 (1.40–1.95) 1.22 (1.13–1.31)
Pooled estimate 1.27 (1.18–1.37) 1.41 (1.09–1.50) 1.29 (1.18–1.40) 1.20 (1.14–1.27) 1.6 (1.51–1.69) 1.16 (1.13–1.18)
I2 23.1% 86.8% 0% 53.4% 70.7% 14%
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w
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in
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T
here
m
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have
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som
e
potential
confounders,
such
as
personality
type
[ 42]
that
w
e
could
not
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due
to
lack
of
data.L
astly,w
e
did
notinclude
cause
of
death
in
our
analyses
and
the
predictive
pow
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of
SR
H
for
cause-speciﬁc
m
ortality
m
ight
have
varied
accord-
ing
to
cause
of
death.
G
iven
the
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older
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L
M
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,the
rising
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of
non-com
m
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diseases
and
the
scarcity
of
studies
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H
in
older
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these
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m
ay
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a
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understand-
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of
the
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betw
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H
and
m
ortality.
O
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m
ay
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H
as
a
sim
ple
m
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in
survey
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to
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vulnerable
groups
of
older
adults
and
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interventions
in
resource-
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settings.
K
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ints
•
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H
is
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in
L
M
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as
a
brief
and
sim
ple
m
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of
overallsubjective
health
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•
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H
m
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to
objective
m
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to
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•
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H
can
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for
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interventions.
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Table 3. The Cox proportional hazards models of the association between SRH and mortality. Moderate SRH used as reference (U = Urban; R = Rural; Dom Rep =
Dominican Republic)
Model 1 Model 2 Model 3 Model 4
Poor SRH Good SRH Poor SRH Good SRH Poor SRH Good SRH Poor SRH Good SRH
Centre
Cuba 1.38 (1.07–1.78) 0.74 (0.62–0.88) 1.17 (0.91–1.51) 0.69 (0.58–0.82) 1.04 (0.79–1.37) 0.75 (0.62–0.91) 0.94 (0.71–1.26) 0.77 (0.64–0.94)
Dom Rep 2.28 (1.75–2.98) 0.97 (0.79–1.18) 2.30 (1.75–3.02) 1.04 (0.85–1.27) 2.19 (1.63–2.93) 1.07 (0.86–1.32) 1.89 (1.40–2.54) 1.14 (0.92–1.42)
Peru (U) 2.92 (1.64–5.19) 0.66 (0.42–1.01) 2.86 (1.57–5.15) 0.70 (0.45–1.08) 2.45 (1.14–5.24) 0.82 (0.49–1.35) 1.90 (0.80–4.52) 1.19 (0.65–2.17)
Peru (R) 3.66 (1.26–10.59) 0.8 (0.46–1.39) 3.58 (1.21–10.54) 0.90 (0.51–1.60) 3.60 (1.06–12.22) 0.96 (0.52–1.78) 3.96 (1.14–13.71) 0.96 (0.51–1.80)
Venezuela 3.34 (2.17–5.16) 0.6 (0.44–0.82) 3.00 (1.93–4.66) 0.59 (0.43–0.81) 2.70 (1.63–4.46) 0.75 (0.53–1.07) 2.49 (1.42–4.36) 0.79 (0.54–1.15)
Mexico (U) 2.34 (1.30–4.21) 1.01 (0.66–1.56) 2.07 (1.14–3.78) 0.92 (0.60–1.43) 1.94 (1.02–3.70) 0.91 (0.57–1.46) 1.71 (0.88–3.35) 0.98 (0.61–1.56)
Mexico (R) 1.89 (1.11–3.23) 0.72 (0.48–1.09) 1.84 (1.07–3.16) 0.71 (0.47–1.07) 1.58 (0.88–2.84) 0.79 (0.51–1.23) 1.31 (0.69–2.47) 0.80 (0.52–1.25)
China (U) 4.12 (2.64–6.44) 1.09 (0.76–1.55) 2.69 (1.70–4.24) 0.81 (0.56–1.15) 1.76 (0.85–3.64) 0.73 (0.49–1.07) 1.39 (0.65–2.98) 0.75 (0.51–1.10)
China (R) 3.27 (2.14–4.99) 0.94 (0.72–1.22) 2.72 (1.77–4.16) 0.87 (0.66–1.14) 1.90 (1.15–3.13) 1.01 (0.75–1.37) 1.87 (1.08–3.24) 1.03 (0.76–1.41)
India (U) 2.38 (1.23–4.62) 0.92 (0.60–1.40) 2.62 (1.32–5.19) 0.85 (0.56–1.30) 1.97 (0.91–4.26) 1.00 (0.64–1.57) 2.03 (0.91–4.49) 1.22 (0.75–1.98)
India (R)
Puerto Rico 1.68 (1.18–2.38) 0.67 (0.52–0.86) 1.62 (1.14–2.31) 0.74 (0.58–0.96) 0.84 (0.51–1.40) 0.75 (0.56–1.01) 0.73 (0.43–1.23) 0.78 (0.58–1.05)
Pooled estimate 2.42 (1.91–3.07) 0.81 (0.74–0.88) 1.97 (1.74–2.23) 0.79 (0.72–0.86) 1.61 (1.40–1.86) 0.86 (0.78–0.94) 1.43 (1.23–1.66) 0.90 (0.82–0.99)
I2 68.7% 38.6% 66.2% 32.9% 64.6% 0% 62.5% 21.9%
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